Catalyst Capital Advisors LLC Moderna, Inc. Transaction History

Catalyst Capital Advisors LLC

$4.3 Billion
Q2 2024

A detailed history of Catalyst Capital Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 370 shares of MRNA stock, worth $24,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares

370

Previous 373 0.8%

Holding current value

$24,327

Previous $39,000 10.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$101.21 - $166.61 $303 - $499	-3 Reduced 0.8%	370 $43,000
Q1 2024 Apr 24, 2024	BUY	$85.37 - $115.44 $1,365 - $1,847	16 Added 4.48%	373 $39,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $5,213 - $7,832	75 Added 26.6%	357 $35,000
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $6,652 - $8,736	69 Added 32.39%	282 $29,000
Q2 2023 Aug 08, 2023	SELL	$118.5 - $160.53 $1,540 - $2,086	-13 Reduced 5.75%	213 $25,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $10,038 - $14,579	-74 Reduced 24.67%	226 $34,000
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $1,420 - $2,520	-12 Reduced 3.85%	300 $54,000
Q3 2022 Nov 08, 2022	SELL	$118.07 - $194.18 $1.22 Million - $2.01 Million	-10,372 Reduced 97.08%	312 $37,000
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $25,885 - $39,026	-221 Reduced 2.03%	10,684 $1.53 Million
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $7,208 - $13,397	57 Added 0.53%	10,905 $1.88 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $2.4 Million - $3.91 Million	10,606 Added 4382.64%	10,848 $2.76 Million
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $665 - $1,453	-3 Reduced 1.22%	242 $93,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $1,039 - $1,879	8 Added 3.38%	245 $58,000
Q1 2021 May 10, 2021	SELL	$109.18 - $185.98 $4,585 - $7,811	-42 Reduced 15.05%	237 $31,000
Q4 2020 Feb 05, 2021	BUY	$65.74 - $169.86 $18,341 - $47,390	279 New	279 $29,000
Q2 2019 Aug 08, 2019	SELL	$13.7 - $28.34 $4,247 - $8,785	-310 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$13.52 - $18.8 $4,191 - $5,828	310 New	310 $5,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Moderna, Inc. Transaction History